News

Joint distraction could preempt knee replacement for OA

Posted on: 25/06/2015 - 20:44

ROME – Knee joint distraction – a method of relieving mechanical stress on the joint by temporarily pinning it – could help some patients with osteoarthritis avoid the need for a knee...

Field of Interest: Rheumatology

Type: News Item

Ebola emergency preparedness in Belgium, Portugal and Romania25 Jun 2015

Posted on: 25/06/2015 - 19:38

New techical report published today presents the main strengths and vulnerabilities of Ebola emergency preparedness. The three countries used the knowledge and experience on health threats accumulated over the last ten years on respiratory diseases: SARS, the A(H1N1) pandemic, MERS-CoV and avian... more

Field of Interest: Infectious diseases

Type: News Item

Counseling key to guiding rheumatic disease treatment during pregnancy

Posted on: 25/06/2015 - 16:49

ROME – New therapies introduced over the past 15 years have vastly improved the lives of patients with rheumatic diseases but are also creating complex treatment scenarios as more female patients...

Field of Interest: Rheumatology

Type: News Item

Counseling key to guiding rheumatic disease treatment during pregnancy

Posted on: 25/06/2015 - 16:49

Field of Interest: Pulmonology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

VANCOUVER, B.C. – Amgen’s recent announcement that it is pulling the plug on further development of the investigational interleukin-17 receptor A inhibitor brodalumab was the red hot topic among...

Field of Interest: Dermatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Rheumatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Rheumatology

Type: News Item

Amgen’s termination of brodalumab stuns psoriasis world

Posted on: 25/06/2015 - 14:06

Field of Interest: Dermatology

Type: News Item

VIDEO: JIA study details impact of biologics on adverse events

Posted on: 24/06/2015 - 14:08

ROME – The rate of adverse events in patients with juvenile idiopathic arthritis appears to climb with the use of more than one biologic agent over time, Dr. Joost Swart reported at the European...

Field of Interest: Rheumatology

Type: News Item

EULAR: Anti-TNF therapy carriers low congenital malformation risk

Posted on: 24/06/2015 - 13:09

ROME – Reassuring new data from the German biologics registry RABBIT presented at the European Congress of Rheumatology indicate that exposure to biologic therapies around the time of conception does...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters